drugset / Trial / NCT05701917

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

NCT05701917

Recruiting 300 enrolled Inari Medical
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.

Timeline

Start
2023-01-06
Primary completion
2026-06-30
Completion
2027-01-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Apixaban Small molecule
Comparator Heparin Other / unclassified
Comparator Rivaroxaban Other / unclassified
Comparator Warfarin Small molecule